000			02273 a2200649 4500
005			20250517182001.0
264		0	_c20180807
008			201808s 0 0 eng d
022			_a1751-2980
024	7		_a10.1111/1751-2980.12551 _2doi
040			_aNLM _beng _cNLM
100	1		_aBerriochoa, Camille A
245	0	0	_aNeoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection. _h[electronic resource]
260			_bJournal of digestive diseases _cNov 2017
300			_a642-649 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntimetabolites, Antineoplastic _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aChemoradiotherapy, Adjuvant
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDose Fractionation, Radiation
650	0	4	_aDrug Combinations
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aIrinotecan
650	0	4	_aLeucovorin _xtherapeutic use
650	0	4	_aLymph Node Excision
650	0	4	_aLymph Nodes _xpathology
650	0	4	_aLymphatic Metastasis
650	0	4	_aMale
650	0	4	_aMargins of Excision
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm, Residual
650	0	4	_aOrganometallic Compounds _xtherapeutic use
650	0	4	_aOrganoplatinum Compounds _xtherapeutic use
650	0	4	_aOxaliplatin
650	0	4	_aPancreatectomy
650	0	4	_aPancreatic Neoplasms _xdiagnostic imaging
650	0	4	_aRadiotherapy, Intensity-Modulated
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Rate
650	0	4	_aTomography, X-Ray Computed
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aGemcitabine
700	1		_aAbdel-Wahab, May
700	1		_aLeyrer, Charles M
700	1		_aKhorana, Alok
700	1		_aMatthew Walsh, R
700	1		_aKumar, Aryavarta M S
773	0		_tJournal of digestive diseases _gvol. 18 _gno. 11 _gp. 642-649
856	4	0	_uhttps://doi.org/10.1111/1751-2980.12551 _zAvailable from publisher's website
999			_c27707416 _d27707416